Ralliant (NYSE:RAL) Issues FY 2026 Earnings Guidance

Ralliant (NYSE:RAL) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 2.530-2.690 for the period, compared to the consensus earnings per share estimate of 2.350. The company issued revenue guidance of $2.2 billion-$2.2 billion, compared to the consensus revenue estimate of $2.2 billion. Ralliant also updated its Q2 2026 guidance to 0.580-0.640 EPS.

Wall Street Analyst Weigh In

Several brokerages have weighed in on RAL. Morgan Stanley reissued an “overweight” rating and set a $45.00 price objective on shares of Ralliant in a report on Friday, February 6th. Truist Financial reduced their price target on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research report on Friday, February 6th. Vertical Research upgraded Ralliant from a “hold” rating to a “buy” rating and set a $45.00 price target for the company in a research note on Friday, February 6th. Oppenheimer lowered their price objective on Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a report on Friday, February 6th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Ralliant in a research note on Monday, May 4th. Seven analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Ralliant presently has a consensus rating of “Moderate Buy” and an average target price of $52.00.

Ralliant Trading Up 19.3%

Shares of NYSE RAL opened at $59.13 on Wednesday. Ralliant has a 12-month low of $37.27 and a 12-month high of $60.14. The company has a market cap of $6.62 billion and a price-to-earnings ratio of 30.17. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38. The stock’s 50 day simple moving average is $44.59 and its 200 day simple moving average is $47.19.

Ralliant (NYSE:RAL) last issued its quarterly earnings data on Tuesday, May 12th. The company reported $0.57 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.08. The company had revenue of $534.60 million for the quarter. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. Equities research analysts expect that Ralliant will post 2.37 EPS for the current year.

Ralliant Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 8th will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, June 8th. Ralliant’s dividend payout ratio (DPR) is 10.20%.

Insiders Place Their Bets

In other Ralliant news, SVP Karen M. Bick sold 2,530 shares of the business’s stock in a transaction dated Thursday, March 5th. The shares were sold at an average price of $46.50, for a total transaction of $117,645.00. Following the completion of the transaction, the senior vice president directly owned 42,652 shares of the company’s stock, valued at $1,983,318. The trade was a 5.60% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Institutional Investors Weigh In On Ralliant

A number of hedge funds have recently made changes to their positions in RAL. UMB Bank n.a. increased its stake in Ralliant by 49.6% during the 4th quarter. UMB Bank n.a. now owns 983 shares of the company’s stock valued at $50,000 after buying an additional 326 shares during the period. Maryland State Retirement & Pension System lifted its stake in shares of Ralliant by 1.5% in the 4th quarter. Maryland State Retirement & Pension System now owns 21,940 shares of the company’s stock worth $1,117,000 after acquiring an additional 329 shares during the period. Xponance LLC boosted its holdings in shares of Ralliant by 9.2% in the fourth quarter. Xponance LLC now owns 6,025 shares of the company’s stock valued at $307,000 after acquiring an additional 509 shares in the last quarter. Palisade Asset Management LLC bought a new position in shares of Ralliant in the third quarter valued at approximately $26,000. Finally, BOKF NA acquired a new position in shares of Ralliant during the third quarter valued at approximately $29,000.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.